S. Teipel

发表

Phosphorylated tau predicts rate of cognitive decline in MCI subjects: A comparative CSF study

K. Blennow, H. Hampel, M. Ewers, 2005, Neurology.

Combined assessment of tau and neuronal thread protein in Alzheimer’s disease CSF

J. Yesavage, E. Shooter, H. Hampel, 2000, Neurology.

EEG coherence reflects regional corpus callosum area in Alzheimer’s disease

H. Möller, G. Juckel, H. Hampel, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease.

P Pietrini, B Horwitz, H. Möller, 1999, Archives of neurology.

Perivascular space enlargement accelerates with hypertension, white matter hyperintensities, chronic inflammation, and Alzheimer's disease pathology: evidence from a three-year longitudinal multicentre study

P. Dechent, A. Spottke, K. Fliessbach, 2023, medRxiv.

Association between Cognitive Performance and Cortical Glucose Metabolism in Patients with Mild Alzheimer’s Disease

P. Bartenstein, A. Bokde, H. Hampel, 2005, Dementia and Geriatric Cognitive Disorders.

Functional and Structural MR Imaging in Neuropsychiatric Disorders, Part 1: Imaging Techniques and Their Application in Mild Cognitive Impairment and Alzheimer Disease

D. Keeser, S. Mueller, S. Teipel, 2012, American Journal of Neuroradiology.

Whole-body modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer’s disease

A. Spottke, K. Fliessbach, B. Bendlin, 2023, Research square.

[Structural magnetic resonance tomography in diagnosis and research of Alzheimer type dementia].

H. Möller, B. Horwitz, H. Hampel, 1997, Der Nervenarzt.

Bayesian meta‐analysis of phase 3 results of aducanumab, lecanemab, donanemab, and high‐dose gantenerumab in prodromal and mild Alzheimer's disease

Anna G. M. Temp, S. Teipel, Michael W Lutz, 2024, Alzheimer's & dementia.